KRQ 10018
Alternative Names: KR-10018Latest Information Update: 16 Jul 2016
At a glance
- Originator Korea Research Institute of Chemical Technology
- Class Antibacterials; Quinolones; Small molecules
- Mechanism of Action DNA gyrase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Bacterial infections; Tuberculosis
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Bacterial-infections in South Korea
- 16 Jul 2016 No recent reports of development identified for preclinical development in Tuberculosis in South Korea (PO)
- 16 Jul 2016 No recent reports of development identified for preclinical development in Tuberculosis in USA (PO)